Want to see IMVT full AI Analyst Report?

Immunovant (IMVT) Revenue

957 Followers

Immunovant Revenue

Immunovant had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2026, Immunovant had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

Employees

362

Market Cap

$7.98B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	―	―	―
Mar 31, 2025	―	―	―
Mar 31, 2024	―	―	―
Mar 31, 2023	―	―	―
Mar 31, 2022	―	―	―
Mar 31, 2021	―	―	―
Mar 31, 2020	―	―	―
Mar 31, 2019	―	―	―
Mar 31, 2018	―	―	―